期刊
JOURNAL OF HEPATOLOGY
卷 35, 期 6, 页码 790-797出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/S0168-8278(01)00215-X
关键词
hepatitis B; immunity; interferon-gamma; hepatitis B virus DNA; viral transcription
Background/Aims: Interferon-gamma (IFN-gamma) has been shown to abolish hepatitis B virus (HBV) gene expression and replication in HBV transgenic mice without destroying infected hepatocytes. We investigated the characteristics of IFN-gamma induced non-cytolytic inhibition of viral replication in human HBV infection. Methods: We used an in vitro model where lymphocytes from 15 HBsAg positive patients were co-cultured with transfected hepatocytes supporting HBV replication. The effector and target cells were separated by a membrane, which allowed transfer of soluble factors only, to determine whether IFN-gamma produced from antigen-specific CD4 + T cells or mitogen stimulated lymphocytes inhibits HBV replication. Results: IFN-gamma produced following lymphocyte stimulation reduced cytoplasmic HBV DNA in the target cells. The degree of HBV DNA reduction correlated with the level of IFN-gamma in the supernatants. Further investigations using naturally infected human hepatocytes confirmed that recombinant IFN-T reduces HBV DNA and HBV RNA in these cells as well, in parallel with the induction of cellular interferon-responsive genes. This antiviral effect was without significant cytotoxicity and was more pronounced in hepatocytes from patients with low HBV replication. Conclusions: These results provide direct evidence that IFN-T can inhibit both HBV transcription and replication in human hepatocytes without cell lysis. (C) 2001 European Association for the Study of the Liver. Published by Elsevier Science B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据